Baseimmune logo

Baseimmune

Pioneering the next generation of active immunotherapies for chronic diseases

29 employees · est. 2019 · London, United Kingdom

VS
LYNK Pharmaceuticals logo

LYNK Pharmaceuticals

Pioneering novel treatments for oncology, immunology, and inflammatory diseases since 2018.

11-50 employees · est. 2018

LYNK Pharmaceuticals is the older company (2019 vs 2018).

Side-by-Side Comparison

Baseimmune LYNK Pharmaceuticals
Founded
2019 2018 older
Headquarters
London, United Kingdom Not tracked yet
Employees
29 11-50
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series A Series C
Total Funding
$13.19M $402.00M
Funding Rounds
4 7
Services
design and development of novel immunotherapies, platform for bespoke antigen creation Not tracked yet
Target Customers
patients with chronic diseases, healthcare providers and professionals, biotech and pharmaceutical companies Not tracked yet
Taxonomy
Active Immunotherapies, Chronic Diseases, Antigen Discovery, Vaccine Development, Biotech Startup, Next Generation Vaccines, Discovery Phase, Immunology, Biotechnology Innovation, Healthtech Startup, Biomedical Research, Preventive Medicine, Pharmaceutical Research Oncology, Immunology, Inflammatory Diseases, Biotech Enterprise, Novel Treatments, Medicine Discovery, Medicine Development, Pharmaceutical Research, Innovative Medicines, Biotechnology Focus, Disease Treatment
Website
baseimmune.co.uk en.lynkpharma.com
Baseimmune logo

About Baseimmune

Baseimmune is a UK-based company founded in 2019, marking its presence in the Biotechnology, Health Care, and Life Sciences industries. Emphasizing its slogan, "Pioneering the next generation of active immunotherapies for chronic diseases," the company operates in the specialized area of antigen dis...

LYNK Pharmaceuticals logo

About LYNK Pharmaceuticals

LYNK Pharmaceuticals, established in 2018, is a promising player in the biotechnology and pharmaceutical sectors. With a focus on pioneering novel treatments for oncology, immunology, and inflammatory diseases, the company is based in Hangzhou, Zhejiang, China. Recently, LYNK Pharmaceuticals secure...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Baseimmune and LYNK Pharmaceuticals — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Baseimmune and LYNK Pharmaceuticals — by email.

Frequently Asked Questions

Baseimmune — Pioneering the next generation of active immunotherapies for chronic diseases. LYNK Pharmaceuticals — Pioneering novel treatments for oncology, immunology, and inflammatory diseases since 2018.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Baseimmune has raised $13.19M while LYNK Pharmaceuticals has raised $402.00M.
Baseimmune and LYNK Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Baseimmune with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy